NLS Pharmaceutics Ltd (NLSP)
0.1399
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
0.138
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Total Return Price: 0.1399 for May 7, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 07, 2024 | 0.1399 |
| May 06, 2024 | 0.136 |
| May 03, 2024 | 0.138 |
| May 02, 2024 | 0.136 |
| May 01, 2024 | 0.1339 |
| April 30, 2024 | 0.1397 |
| April 29, 2024 | 0.1416 |
| April 26, 2024 | 0.1367 |
| April 25, 2024 | 0.1324 |
| April 24, 2024 | 0.125 |
| April 23, 2024 | 0.1302 |
| April 22, 2024 | 0.1299 |
| April 19, 2024 | 0.1327 |
| April 18, 2024 | 0.1327 |
| April 17, 2024 | 0.133 |
| April 16, 2024 | 0.137 |
| April 15, 2024 | 0.1415 |
| April 12, 2024 | 0.1496 |
| April 11, 2024 | 0.1535 |
| April 10, 2024 | 0.1496 |
| April 09, 2024 | 0.1493 |
| April 08, 2024 | 0.1406 |
| April 05, 2024 | 0.1422 |
| April 04, 2024 | 0.1542 |
| April 03, 2024 | 0.16 |
| Date | Value |
|---|---|
| April 02, 2024 | 0.1759 |
| April 01, 2024 | 0.1724 |
| March 28, 2024 | 0.18 |
| March 27, 2024 | 0.1651 |
| March 26, 2024 | 0.1748 |
| March 25, 2024 | 0.1655 |
| March 22, 2024 | 0.18 |
| March 21, 2024 | 0.1699 |
| March 20, 2024 | 0.157 |
| March 19, 2024 | 0.2694 |
| March 18, 2024 | 0.2698 |
| March 15, 2024 | 0.309 |
| March 14, 2024 | 0.3349 |
| March 13, 2024 | 0.3414 |
| March 12, 2024 | 0.33 |
| March 11, 2024 | 0.3694 |
| March 08, 2024 | 0.339 |
| March 07, 2024 | 0.355 |
| March 06, 2024 | 0.354 |
| March 05, 2024 | 0.355 |
| March 04, 2024 | 0.3501 |
| March 01, 2024 | 0.3576 |
| February 29, 2024 | 0.3868 |
| February 28, 2024 | 0.385 |
| February 27, 2024 | 0.39 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.125
Minimum
Apr 24 2024
5.85
Maximum
Mar 12 2021
1.392
Average
1.04
Median
Feb 07 2022
Total Return Price Benchmarks
| AC Immune SA | 2.38 |
| CRISPR Therapeutics AG | 55.56 |
| Addex Therapeutics Ltd | 9.15 |
| Molecular Partners AG | 3.65 |
| MoonLake Immunotherapeutics | 43.67 |